INZY
Inozyme Pharma
INZY
INZY
Delisted
INZY was delisted on the 30th of June, 2025.
54 hedge funds and large institutions have $379M invested in Inozyme Pharma in 2020 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 20 increasing their positions, 7 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
2% more funds holding
Funds holding: 53 → 54 (+1)
11% less capital invested
Capital invested by funds: $428M → $379M (-$48.7M)
Holders
54
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$4.42M | |
| 2 | +$3.52M | |
| 3 | +$2.77M | |
| 4 |
BlackRock
New York
|
+$2.68M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$2M |
Top Sellers
| 1 | -$5.16M | |
| 2 | -$1.08M | |
| 3 | -$1.02M | |
| 4 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$633K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$326K |